Article

Empiric Quadruple vs. Triple Therapy for Primary Treatment of Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Efficacy and Tolerability

University of Michigan Medical Center, Ann Arbor, USA.
The American Journal of Gastroenterology (Impact Factor: 9.21). 09/2009; 105(1):65-73. DOI: 10.1038/ajg.2009.508
Source: PubMed

ABSTRACT Recent treatment guidelines recommend two first-line therapies for Helicobacter pylori infection: proton pump inhibitor (PPI), bismuth, tetracycline, and metronidazole (quadruple therapy) or PPI, clarithromycin, and amoxicillin (triple therapy). We performed a systematic review and meta-analysis to compare the efficacy and tolerability of these regimens as first-line treatment of H. pylori.
A search of MEDLINE, EMBASE, Google Scholar, the Cochrane Central Register of Controlled Trials, ACP Journal Club, the Database of Abstracts of Reviews of Effectiveness, Cochrane Methodology Register, Health Technology Assessment Database, and abstracts from prominent gastrointestinal scientific meetings was carried out. Randomized controlled trials (RCTs) comparing bismuth quadruple therapy to clarithromycin triple therapy were selected for meta-analysis. Two independent reviewers extracted data, using standardized data forms. Meta-analysis was carried out with the metan command in Stata 10.1. Funnel plots and subgroup analyses were carried out.
Nine RCTs (N=1,679) were included. Although dosing regimens of clarithromycin triple therapy were quite consistent between trials, dosing regimens varied considerably for bismuth quadruple therapy. Bismuth quadruple therapy achieved eradication in 78.3% of patients, whereas clarithromycin triple therapy achieved an eradication rate of 77.0% (risk ratio (RR)=1.002, 95% confidence interval (CI): 0.936-1.073). There was moderate heterogeneity and no evidence for significant publication bias. Subgroup analyses by study location, treatment duration, and study population did not account for the heterogeneity. There were no statistically significant differences in side effects yielded by quadruple vs. clarithromycin triple therapy (RR=1.04, 95% CI: 1.04-1.14).
Quadruple and triple therapies yielded similar eradication rates as primary therapy for H. pylori infection. Both therapies yielded suboptimal eradication rates. Patient compliance and side effects are similar for quadruple and triple therapies.

Download full-text

Full-text

Available from: Paul Moayyedi, Nov 09, 2014
1 Follower
 · 
141 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: With the rising prevalence of antimicrobial resistance, the eradication rates of Helicobacter pylori (H. pylori) with standard treatments are decreasing to unacceptable levels (i.e., ≤80%) in most countries. After these disappointing results, several authorities have proposed that infection with H. pylori should be approached and treated as any other bacterial infectious disease. This implicates that clinicians should prescribe empirical treatments yielding a per protocol eradication of at least 90%. In recent years several treatments producing ≥90% cure rates have been proposed including sequential therapy, concomitant quadruple therapy, hybrid (dual-concomitant) therapy, and bismuth-containing quadruple therapy. These treatments are likely to represent the recommended first-line treatments in the near future. In the present paper, we are considering a series of critical issues regarding currently available means and approaches for the management of H. pylori infection. Clinical needs and realistic endpoints are taken into account. Furthermore, emerging strategies for the eradication of H. pylori and the existing evidence of their clinical validation and widespread applicability are discussed.
    Gastroenterology Research and Practice 06/2012; 2012:757926. DOI:10.1155/2012/757926
  • [Show abstract] [Hide abstract]
    ABSTRACT: For accurate activity per unit volume measurements in SPECT, recovery coefficients are usually applied based on the size and shape of objects being imaged to properly account for the resolution limitations of the gamma camera. Because of noise and limited spatial resolution, determination of object sizes and boundaries can be difficult using the SPECT images alone. The authors therefore have developed a technique which determines activity concentrations for SPECT using regions of interest (ROIs) obtained from coregistered X-ray CT images. In this study, experimental phantoms containing cylindrical and spherical objects were imaged on a combined X-ray CT/SPECT system and reconstructed data volumes were registered using the known geometry of the system. ROI's were defined on the registered CT images and used to help quantify activity concentration in localized regions and to measure object volumes. The authors have derived the recovery curves for these objects and scan technique. They have also tested a technique that demonstrates activity quantitation without the need for object and size dependent recovery coefficients in the case of low background
    IEEE Transactions on Nuclear Science 09/1997; DOI:10.1109/23.632738
  • Conference Paper: Beam-based BPM alignment
    [Show abstract] [Hide abstract]
    ABSTRACT: An operational, beam-based, -measurement, control room procedure designed to steer the closed orbit through the effective (no steer) center of every quadrupole is described. Performance of the procedure is simulated using UAL (Unified Accelerator Libraries). Matching SNS hardware availability, quadrupole strengths are assumed to be trimmable, but only in families, not individually. The accuracy of the procedure is unaffected by geometric and/or electrical misalignment of BPM's (beam position monitors) but calibration of their misalignments is a byproduct of the procedure. Some of the many possible failure mechanisms have been modeled, and have been found not to invalidate the procedure.
    Particle Accelerator Conference, 2003. PAC 2003. Proceedings of the; 06/2003